TY - JOUR AU - Mukadi, Y. D. AU - Maher, D. AU - Harries, A. PY - 2001 DA - 2001// TI - Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa JO - AIDS VL - 15 UR - https://doi.org/10.1097/00002030-200101260-00002 DO - 10.1097/00002030-200101260-00002 ID - Mukadi2001 ER - TY - JOUR AU - Zhou, J. AU - Elliott, J. AU - Li, P. C. AU - Lim, P. L. AU - Kiertiburanakul, S. AU - Kumarasamy, N. PY - 2009 DA - 2009// TI - Risk and prognostic significance of tuberculosis in patients from the treat Asia HIV observational database JO - BMC Infect Dis VL - 9 UR - https://doi.org/10.1186/1471-2334-9-46 DO - 10.1186/1471-2334-9-46 ID - Zhou2009 ER - TY - JOUR AU - Balcha, T. T. AU - Skogmar, S. AU - Sturegård, E. AU - Björkman, P. AU - Winqvist, N. PY - 2015 DA - 2015// TI - Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding JO - Glob Health Action VL - 8 ID - Balcha2015 ER - TY - JOUR AU - Manosuthi, W. AU - Chottanapand, S. AU - Thongyen, S. AU - Chaovavanich, A. AU - Sungkanuparph, S. PY - 2006 DA - 2006// TI - Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy JO - J Acquir Immune Defic Syndr VL - 43 UR - https://doi.org/10.1097/01.qai.0000230521.86964.86 DO - 10.1097/01.qai.0000230521.86964.86 ID - Manosuthi2006 ER - TY - JOUR AU - Sungkanuparph, S. AU - Manosuthi, W. AU - Kiertiburanakul, S. AU - Vibhagool, A. PY - 2006 DA - 2006// TI - Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand JO - J Infect VL - 52 UR - https://doi.org/10.1016/j.jinf.2005.05.010 DO - 10.1016/j.jinf.2005.05.010 ID - Sungkanuparph2006 ER - TY - JOUR AU - Manosuthi, W. AU - Chaovavanich, A. AU - Tansuphaswadikul, S. AU - Prasithsirikul, W. AU - Inthong, Y. AU - Chottanapund, S. PY - 2007 DA - 2007// TI - Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting JO - J Infect VL - 55 UR - https://doi.org/10.1016/j.jinf.2007.07.002 DO - 10.1016/j.jinf.2007.07.002 ID - Manosuthi2007 ER - TY - JOUR AU - Sungkanuparph, S. AU - Vibhagool, A. AU - Mootsikapun, P. AU - Chetchotisakd, P. AU - Tansuphaswaswadikul, S. AU - Bowonwatanuwong, C. PY - 2003 DA - 2003// TI - Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis JO - AIDS VL - 17 UR - https://doi.org/10.1097/00002030-200309260-00018 DO - 10.1097/00002030-200309260-00018 ID - Sungkanuparph2003 ER - TY - JOUR AU - Coker, R. J. AU - Hellyer, T. J. AU - Brown, I. N. AU - Weber, J. N. PY - 1992 DA - 1992// TI - Clinical aspects of mycobacterial infections in HIV infection JO - Res Microbiol VL - 143 UR - https://doi.org/10.1016/0923-2508(92)90049-T DO - 10.1016/0923-2508(92)90049-T ID - Coker1992 ER - TY - JOUR AU - Reid, M. J. AU - Shah, N. S. PY - 2009 DA - 2009// TI - Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings JO - Lancet Infect Dis VL - 9 UR - https://doi.org/10.1016/S1473-3099(09)70043-X DO - 10.1016/S1473-3099(09)70043-X ID - Reid2009 ER - TY - JOUR AU - Cain, K. P. AU - McCarthy, K. D. AU - Heilig, C. M. AU - Monkongdee, P. AU - Tasaneeyapan, T. AU - Kanara, N. PY - 2010 DA - 2010// TI - An algorithm for tuberculosis screening and diagnosis in people with HIV JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0907488 DO - 10.1056/NEJMoa0907488 ID - Cain2010 ER - TY - JOUR AU - Geng, E. AU - Kreiswirth, B. AU - Burzynski, J. AU - Schluger, N. W. PY - 2005 DA - 2005// TI - Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study JO - JAMA VL - 293 UR - https://doi.org/10.1001/jama.293.22.2740 DO - 10.1001/jama.293.22.2740 ID - Geng2005 ER - TY - JOUR AU - Perlman, D. C. AU - el-Sadr, W. M. AU - Nelson, E. T. AU - Matts, J. P. AU - Telzak, E. E. AU - Salomon, N. PY - 1997 DA - 1997// TI - Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) JO - Clin Infect Dis VL - 25 UR - https://doi.org/10.1086/514546 DO - 10.1086/514546 ID - Perlman1997 ER - TY - JOUR AU - Chaisson, R. E. AU - Schecter, G. F. AU - Theuer, C. P. AU - Rutherford, G. W. AU - Echenberg, D. F. PY - 1987 DA - 1987// TI - Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival JO - Am Rev Respir Dis VL - 136 UR - https://doi.org/10.1164/ajrccm/136.3.570 DO - 10.1164/ajrccm/136.3.570 ID - Chaisson1987 ER - TY - JOUR AU - Greenberg, S. D. AU - Frager, D. AU - Suster, B. AU - Walker, S. AU - Stavropoulos, C. AU - Rothpearl, A. PY - 1994 DA - 1994// TI - Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance) JO - Radiology VL - 193 UR - https://doi.org/10.1148/radiology.193.1.7916467 DO - 10.1148/radiology.193.1.7916467 ID - Greenberg1994 ER - TY - JOUR AU - Pepper, T. AU - Joseph, P. AU - Mwenya, C. AU - McKee, G. S. AU - Haushalter, A. AU - Carter, A. PY - 2008 DA - 2008// TI - Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures JO - Int J Tuberc Lung Dis VL - 12 ID - Pepper2008 ER - TY - JOUR AU - Chaisson, R. E. AU - Schecter, G. F. AU - Theuer, C. P. AU - Rutherford, G. W. AU - Echenberg, D. F. AU - Hopewell, P. C. PY - 1987 DA - 1987// TI - Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival JO - Am Rev Respir Dis VL - 136 UR - https://doi.org/10.1164/ajrccm/136.3.570 DO - 10.1164/ajrccm/136.3.570 ID - Chaisson1987 ER - TY - JOUR AU - Rajasekaran, S. AU - Mahilmaran, A. AU - Annadurai, S. AU - Kumar, S. AU - Raja, K. PY - 2007 DA - 2007// TI - Manifestation of tuberculosis in patients with human immunodeficiency virus: a large Indian study JO - Ann Thorac Med VL - 2 UR - https://doi.org/10.4103/1817-1737.32231 DO - 10.4103/1817-1737.32231 ID - Rajasekaran2007 ER - TY - JOUR AU - Jones, B. E. AU - Young, S. M. AU - Antoniskis, D. AU - Davidson, P. T. AU - Kramer, F. AU - Barnes, P. F. PY - 1993 DA - 1993// TI - Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection JO - Am Rev Respir Dis VL - 148 UR - https://doi.org/10.1164/ajrccm/148.5.1292 DO - 10.1164/ajrccm/148.5.1292 ID - Jones1993 ER - TY - JOUR AU - Shafer, R. W. AU - Kim, D. S. AU - Weiss, J. P. AU - Quale, J. M. PY - 1991 DA - 1991// TI - Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection JO - Medicine VL - 70 UR - https://doi.org/10.1097/00005792-199111000-00004 DO - 10.1097/00005792-199111000-00004 ID - Shafer1991 ER - TY - JOUR AU - Török, M. E. AU - Yen, N. T. AU - Chau, T. T. AU - Mai, N. T. AU - Phu, N. H. AU - Mai, P. P. PY - 2011 DA - 2011// TI - Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis JO - Clin Infect Dis VL - 52 UR - https://doi.org/10.1093/cid/cir230 DO - 10.1093/cid/cir230 ID - Török2011 ER - TY - JOUR AU - Gray, J. M. AU - Cohn, D. L. PY - 2013 DA - 2013// TI - Tuberculosis and HIV coinfection JO - Semin Respir Crit Care Med VL - 34 UR - https://doi.org/10.1055/s-0032-1333469 DO - 10.1055/s-0032-1333469 ID - Gray2013 ER - TY - JOUR AU - Steingart, K. R. AU - Ng, V. AU - Henry, M. AU - Hopewell, P. C. AU - Ramsay, A. AU - Cunningham, J. PY - 2006 DA - 2006// TI - Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review JO - Lancet Infect Dis VL - 60 UR - https://doi.org/10.1016/S1473-3099(06)70602-8 DO - 10.1016/S1473-3099(06)70602-8 ID - Steingart2006 ER - TY - JOUR AU - Samb, B. AU - Sow, P. S. AU - Kony, S. AU - Maynart-Badiane, M. AU - Diouf, G. AU - Cissokho, S. PY - 1999 DA - 1999// TI - Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence JO - Int J Tuberc Lung Dis VL - 3 ID - Samb1999 ER - TY - JOUR AU - Apers, L. AU - Wijarajah, C. AU - Mutsvangwa, J. AU - Chigara, N. AU - Mason, P. AU - Stuyft, P. PY - 2004 DA - 2004// TI - Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence JO - Int J Tuberc Lung Dis VL - 8 ID - Apers2004 ER - TY - JOUR AU - Zumla, A. AU - Raviglione, M. AU - Hafner, R. AU - Reyn, C. F. PY - 2013 DA - 2013// TI - Tuberculosis JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMra1200894 DO - 10.1056/NEJMra1200894 ID - Zumla2013 ER - TY - JOUR AU - Drobniewski, F. A. AU - Caws, M. AU - Gibson, A. AU - Young, D. PY - 2003 DA - 2003// TI - Modern laboratory diagnosis of tuberculosis JO - Lancet Infect Dis VL - 3 UR - https://doi.org/10.1016/S1473-3099(03)00544-9 DO - 10.1016/S1473-3099(03)00544-9 ID - Drobniewski2003 ER - TY - JOUR AU - Sungkanuparph, S. AU - Eampokalap, B. AU - Chottanapund, S. AU - Thongyen, S. AU - Manosuthi, W. PY - 2007 DA - 2007// TI - Impact of drug-resistant tuberculosis on the survival of HIV-infected patients JO - Int J Tuberc Lung Dis VL - 11 ID - Sungkanuparph2007 ER - TY - JOUR AU - Chung-Delgado, K. AU - Guillen-Bravo, S. AU - Revilla-Montag, A. AU - Bernabe-Ortiz, A. PY - 2015 DA - 2015// TI - Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119332 DO - 10.1371/journal.pone.0119332 ID - Chung-Delgado2015 ER - TY - BOOK PY - 2013 DA - 2013// TI - Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system: policy update PB - World Health Organization CY - Geneva ID - ref29 ER - TY - JOUR AU - Scott, L. E. AU - McCarthy, K. AU - Gous, N. AU - Nduna, M. AU - Rie, A. AU - Sanne, I. PY - 2011 DA - 2011// TI - Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study JO - PLoS Med VL - 8 UR - https://doi.org/10.1371/journal.pmed.1001061 DO - 10.1371/journal.pmed.1001061 ID - Scott2011 ER - TY - JOUR AU - Dheda, K. AU - Davids, V. AU - Lenders, L. AU - Roberts, T. AU - Meldau, R. AU - Ling, D. PY - 2010 DA - 2010// TI - Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0009848 DO - 10.1371/journal.pone.0009848 ID - Dheda2010 ER - TY - JOUR AU - Drain, P. K. AU - Losina, E. AU - Coleman, S. M. AU - Giddy, J. AU - Ross, D. AU - Katz, J. N. PY - 2015 DA - 2015// TI - Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis JO - J Acquir Immune Defic Syndr VL - 68 UR - https://doi.org/10.1097/QAI.0000000000000436 DO - 10.1097/QAI.0000000000000436 ID - Drain2015 ER - TY - JOUR AU - Peter, J. G. AU - Zijenah, L. S. AU - Chanda, D. AU - Clowes, P. AU - Lesosky, M. AU - Gina, P. PY - 2016 DA - 2016// TI - Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01092-2 DO - 10.1016/S0140-6736(15)01092-2 ID - Peter2016 ER - TY - JOUR AU - Purohit, M. R. AU - Mustafa, T. AU - Wiker, H. G. AU - Morkve, O. AU - Sviland, L. PY - 2007 DA - 2007// TI - Immunohistochemical diagnosis of abdominal and lymph node tuberculosis by detecting Mycobacterium tuberculosis complex specific antigen MPT64 JO - Diagn Pathol VL - 2 UR - https://doi.org/10.1186/1746-1596-2-36 DO - 10.1186/1746-1596-2-36 ID - Purohit2007 ER - TY - JOUR AU - Purohit, M. R. AU - Mustafa, T. AU - Wiker, H. G. AU - Sviland, L. PY - 2012 DA - 2012// TI - Rapid diagnosis of tuberculosis in aspirate, effusions, and cerebrospinal fluid by immunocytochemical detection of Mycobacterium tuberculosis complex specific antigen MPT64 JO - Diagn Cytopathol VL - 40 UR - https://doi.org/10.1002/dc.21637 DO - 10.1002/dc.21637 ID - Purohit2012 ER - TY - JOUR AU - Denkinger, C. M. AU - Schumacher, S. G. AU - Boehme, C. C. AU - Dendukuri, N. AU - Pai, M. AU - Steingart, K. R. PY - 2014 DA - 2014// TI - Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and metaanalysis JO - Eur Respir J VL - 44 UR - https://doi.org/10.1183/09031936.00007814 DO - 10.1183/09031936.00007814 ID - Denkinger2014 ER - TY - JOUR AU - Shriner, K. A. AU - Mathisen, G. E. AU - Goetz, M. B. PY - 1992 DA - 1992// TI - Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls JO - Clin Infect Dis VL - 15 UR - https://doi.org/10.1093/clind/15.4.601 DO - 10.1093/clind/15.4.601 ID - Shriner1992 ER - TY - JOUR AU - Purohit, M. AU - Mustafa, T. PY - 2015 DA - 2015// TI - Laboratory diagnosis of extra-pulmonary tuberculosis (EPTB) in resource-constrained setting: state of the art, challenges and the need JO - J Clin Diagn Res VL - 9 UR - https://doi.org/10.1111/crj.12091 DO - 10.1111/crj.12091 ID - Purohit2015 ER - TY - JOUR AU - Dinnes, J. AU - Deeks, J. AU - Kunst, H. AU - Gibson, A. AU - Cummins, E. AU - Waugh, N. PY - 2007 DA - 2007// TI - A systematic review of rapid diagnostic tests for the detection of tuberculosis infection JO - Health Technol Assess VL - 11 UR - https://doi.org/10.3310/hta11030 DO - 10.3310/hta11030 ID - Dinnes2007 ER - TY - JOUR AU - Blanc, F. X. AU - Sok, T. AU - Laureillard, D. AU - Borand, L. AU - Rekacewicz, C. AU - Nerrienet, E. PY - 2011 DA - 2011// TI - Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1013911 DO - 10.1056/NEJMoa1013911 ID - Blanc2011 ER - TY - JOUR AU - Abdool Karim, S. S. AU - Naidoo, K. AU - Grobler, A. AU - Padayatchi, N. AU - Baxter, C. AU - Gray, A. PY - 2010 DA - 2010// TI - Timing of initiation of antiretroviral drugs during tuberculosis therapy JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0905848 DO - 10.1056/NEJMoa0905848 ID - Abdool Karim2010 ER - TY - JOUR AU - Abdool Karim, S. S. AU - Naidoo, K. AU - Grobler, A. AU - Padayatchi, N. AU - Baxter, C. AU - Gray, A. L. PY - 2011 DA - 2011// TI - Integration of antiretroviral therapy with tuberculosis treatment JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1014181 DO - 10.1056/NEJMoa1014181 ID - Abdool Karim2011 ER - TY - JOUR AU - Havlir, D. V. AU - Kendall, M. A. AU - Ive, P. AU - Kumwenda, J. AU - Swindells, S. AU - Qasba, S. S. PY - 2011 DA - 2011// TI - Timing of antiretroviral therapy for HIV-1 infection and tuberculosis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1013607 DO - 10.1056/NEJMoa1013607 ID - Havlir2011 ER - TY - JOUR AU - Manosuthi, W. AU - Mankatitham, W. AU - Lueangniyomkul, A. AU - Thongyen, S. AU - Likanonsakul, S. AU - Suwanvattana, P. PY - 2012 DA - 2012// TI - Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study JO - J Acquir Immune Defic Syndr VL - 60 UR - https://doi.org/10.1097/QAI.0b013e31825b5e06 DO - 10.1097/QAI.0b013e31825b5e06 ID - Manosuthi2012 ER - TY - JOUR AU - Uthman, O. A. AU - Okwundu, C. AU - Gbenga, K. AU - Volmink, J. AU - Dowdy, D. AU - Zumla, A. PY - 2015 DA - 2015// TI - Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis JO - Ann Intern Med VL - 163 UR - https://doi.org/10.7326/M14-2979 DO - 10.7326/M14-2979 ID - Uthman2015 ER - TY - JOUR AU - Mfinanga, S. G. AU - Kirenga, B. J. AU - Chanda, D. M. AU - Mutayoba, B. AU - Mthiyane, T. AU - Yimer, G. PY - 2014 DA - 2014// TI - Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70733-9 DO - 10.1016/S1473-3099(14)70733-9 ID - Mfinanga2014 ER - TY - STD TI - World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. http://www.who.int/hiv/pub/guidelines/arv2013/. Accessed 26 Dec 2015. UR - http://www.who.int/hiv/pub/guidelines/arv2013/ ID - ref47 ER - TY - STD TI - World Health Organisation. WHO global tuberculosis report 2015. http://apps.who.int/iris/bitstream/10665/44165/1/9789241547833_eng.pdf?ua=1&ua=1. Accessed 27 Feb 2016. UR - http://apps.who.int/iris/bitstream/10665/44165/1/9789241547833_eng.pdf%3fua%3d1%26ua%3d1 ID - ref48 ER - TY - STD TI - World Health Organization. WHO policy on collaborative TB/HIV activities: Guidelines for national programmes and other stakeholders. http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/. Accessed 26 Dec 2015. UR - http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/ ID - ref49 ER - TY - JOUR AU - Lawn, S. D. AU - Campbell, L. AU - Kaplan, R. AU - Little, F. AU - Morrow, C. AU - Wood, R. PY - 2011 DA - 2011// TI - Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township JO - BMC Infect Dis VL - 11 UR - https://doi.org/10.1186/1471-2334-11-258 DO - 10.1186/1471-2334-11-258 ID - Lawn2011 ER - TY - JOUR AU - Frasca, K. AU - Cohn, J. PY - 2014 DA - 2014// TI - Integration of HIV and tuberculosis in the community JO - J Int Assoc Provid AIDS Care VL - 13 UR - https://doi.org/10.1177/2325957413488183 DO - 10.1177/2325957413488183 ID - Frasca2014 ER - TY - JOUR AU - Owiti, P. AU - Zachariah, R. AU - Bissell, K. AU - Kumar, A. M. AU - Diero, L. AU - Carter, E. J. PY - 2015 DA - 2015// TI - Integrating tuberculosis and HIV services in rural Kenya: uptake and outcomes JO - Public Health Action VL - 5 UR - https://doi.org/10.5588/pha.14.0092 DO - 10.5588/pha.14.0092 ID - Owiti2015 ER - TY - JOUR AU - Legido-Quigley, H. AU - Montgomery, C. M. AU - Khan, P. AU - Atun, R. AU - Fakoya, A. AU - Getahun, H. PY - 2013 DA - 2013// TI - Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review JO - Trop Med Int Health VL - 18 UR - https://doi.org/10.1111/tmi.12029 DO - 10.1111/tmi.12029 ID - Legido-Quigley2013 ER - TY - JOUR AU - Fox, W. AU - Ellard, G. A. AU - Mitchison, D. A. PY - 1999 DA - 1999// TI - Studies on the treatment of tuberculosis undertaken by the British medical research council tuberculosis units, 1946–1986, with relevant subsequent publications JO - Int J Tuberc Lung Dis VL - 3 ID - Fox1999 ER - TY - JOUR AU - Mitchison, D. AU - Davies, G. PY - 2012 DA - 2012// TI - The chemotherapy of tuberculosis: past, present and future JO - Int J Tuberc Lung Dis. VL - 16 UR - https://doi.org/10.5588/ijtld.12.0083 DO - 10.5588/ijtld.12.0083 ID - Mitchison2012 ER - TY - JOUR PY - 1981 DA - 1981// TI - Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months JO - Tubercle VL - 62 UR - https://doi.org/10.1016/0041-3879(81)90016-7 DO - 10.1016/0041-3879(81)90016-7 ID - ref56 ER - TY - JOUR PY - 1984 DA - 1984// TI - A controlled trial of 6 months’ chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond JO - Br J Dis Chest VL - 78 UR - https://doi.org/10.1016/0007-0971(84)90165-7 DO - 10.1016/0007-0971(84)90165-7 ID - ref57 ER - TY - STD TI - World Health Organization. Treatment of tuberculosis: guidelines for national programmes, 4th ed. 2010. http://www.who.int/tb/publications/tb_treatmentguidelines/en/. Accessed 16 Feb 2016. UR - http://www.who.int/tb/publications/tb_treatmentguidelines/en/ ID - ref58 ER - TY - STD TI - National Collaborating Centre for Chronic Conditions and the Centre for Clinical Practice at NICE. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians of London; 2011. http://www.nice.org.uk/nicemedia/live/13422/53638/53638.pdf. Accessed 16 Feb 2016. UR - http://www.nice.org.uk/nicemedia/live/13422/53638/53638.pdf ID - ref59 ER - TY - JOUR AU - Blumberg, H. M. AU - Burman, W. J. AU - Chaisson, R. E. AU - Daley, C. L. AU - Etkind, S. C. AU - Friedman, L. N. PY - 2003 DA - 2003// TI - American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis JO - Am J Respir Crit Care Med VL - 15 ID - Blumberg2003 ER - TY - JOUR AU - Horsburgh, C. R. AU - Barry, C. E. AU - Lange, C. PY - 2015 DA - 2015// TI - Treatment of tuberculosis JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMra1413919 DO - 10.1056/NEJMra1413919 ID - Horsburgh2015 ER - TY - JOUR AU - Gillespie, S. H. AU - Crook, A. M. AU - McHugh, T. D. AU - Mendel, C. M. AU - Meredith, S. K. AU - Murray, S. R. PY - 2014 DA - 2014// TI - Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1407426 DO - 10.1056/NEJMoa1407426 ID - Gillespie2014 ER - TY - JOUR AU - Jindani, A. AU - Harrison, T. S. AU - Nunn, A. J. AU - Phillips, P. P. AU - Churchyard, G. J. AU - Charalambous, S. PY - 2014 DA - 2014// TI - High-dose rifapentine with moxifloxacin for pulmonary tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1314210 DO - 10.1056/NEJMoa1314210 ID - Jindani2014 ER - TY - JOUR AU - Merle, C. S. AU - Fielding, K. AU - Sow, O. B. AU - Gninafon, M. AU - Lo, M. B. AU - Mthiyane, T. PY - 2014 DA - 2014// TI - A four-month gatifloxacin-containing regimen for treating tuberculosis JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1315817 DO - 10.1056/NEJMoa1315817 ID - Merle2014 ER - TY - JOUR AU - Mitchison, D. A. PY - 2000 DA - 2000// TI - Role of individual drugs in the chemotherapy of tuberculosis JO - Int J Tuberc Lung Dis VL - 4 ID - Mitchison2000 ER - TY - JOUR AU - Prasad, K. AU - Singh, M. B. PY - 2008 DA - 2008// TI - Corticosteroids for managing tuberculous meningitis JO - Cochrane Database Syst Rev. VL - 1 ID - Prasad2008 ER - TY - JOUR AU - Mayosi, B. M. AU - Ntsekhe, M. AU - Volmink, J. A. AU - Commerford, P. J. PY - 2002 DA - 2002// TI - Interventions for treating tuberculous pericarditis JO - Cochrane Database Syst Rev. VL - 4 ID - Mayosi2002 ER - TY - JOUR AU - Heemskerk, A. D. AU - Bang, N. D. AU - Mai, N. T. AU - Chau, T. T. AU - Phu, N. H. AU - Loc, P. P. PY - 2016 DA - 2016// TI - Intensified antituberculosis therapy in adults with tuberculous meningitis JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1507062 DO - 10.1056/NEJMoa1507062 ID - Heemskerk2016 ER - TY - STD TI - Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 19 Feb 2016. UR - http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf ID - ref69 ER - TY - JOUR PY - 2011 DA - 2011// TI - British HIV Association guidelines for the treatment of TB/HIV coinfection 2011 JO - HIV Med VL - 12 UR - https://doi.org/10.1111/j.1468-1293.2011.00954.x DO - 10.1111/j.1468-1293.2011.00954.x ID - ref70 ER - TY - JOUR AU - Kassim, S. AU - Sassan-Morokro, M. AU - Ackah, A. AU - Abouya, L. Y. AU - Digbeu, H. AU - Yesso, G. PY - 1995 DA - 1995// TI - Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa JO - AIDS VL - 9 UR - https://doi.org/10.1097/00002030-199510000-00011 DO - 10.1097/00002030-199510000-00011 ID - Kassim1995 ER - TY - JOUR AU - Sterling, T. R. AU - Alwood, K. AU - Gachuhi, R. AU - Coggin, W. AU - Blazes, D. AU - Bishai, W. R. PY - 1999 DA - 1999// TI - Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons JO - AIDS VL - 13 UR - https://doi.org/10.1097/00002030-199910010-00012 DO - 10.1097/00002030-199910010-00012 ID - Sterling1999 ER - TY - JOUR AU - el-Sadr, W. M. AU - Perlman, D. C. AU - Matts, J. P. AU - Nelson, E. T. AU - Cohn, D. L. AU - Salomon, N. PY - 1998 DA - 1998// TI - Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG) JO - Clin Infect Dis VL - 26 UR - https://doi.org/10.1086/520275 DO - 10.1086/520275 ID - el-Sadr1998 ER - TY - JOUR AU - Ahmed Khan, F. AU - Minion, J. AU - Al-Motairi, A. AU - Benedetti, A. AU - Harries, A. D. AU - Menzies, D. PY - 2012 DA - 2012// TI - An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis630 DO - 10.1093/cid/cis630 ID - Ahmed Khan2012 ER - TY - JOUR AU - Ahmad Khan, F. AU - Minion, J. AU - Pai, M. AU - Royce, S. AU - Burman, W. AU - Harries, A. D. PY - 2010 DA - 2010// TI - Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis JO - Clin Infect Dis VL - 50 UR - https://doi.org/10.1086/651686 DO - 10.1086/651686 ID - Ahmad Khan2010 ER - TY - JOUR AU - Aaron, L. AU - Saadoun, D. AU - Calatroni, I. AU - Launay, O. AU - Mémain, N. AU - Vincent, V. PY - 2004 DA - 2004// TI - Tuberculosis in HIV-infected patients: a comprehensive review JO - Clin Microbiol Infect VL - 10 UR - https://doi.org/10.1111/j.1469-0691.2004.00758.x DO - 10.1111/j.1469-0691.2004.00758.x ID - Aaron2004 ER - TY - JOUR AU - Naiker, S. AU - Connolly, C. AU - Wiesner, L. AU - Kellerman, T. AU - Reddy, T. AU - Harries, A. PY - 2014 DA - 2014// TI - Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy JO - BMC Pharmacol Toxicol VL - 15 UR - https://doi.org/10.1186/2050-6511-15-61 DO - 10.1186/2050-6511-15-61 ID - Naiker2014 ER - TY - JOUR AU - Davies, G. AU - Cerri, S. AU - Richeldi, L. PY - 2007 DA - 2007// TI - Rifabutin for treating pulmonary tuberculosis JO - Cochrane Database Syst Rev VL - 4 ID - Davies2007 ER - TY - JOUR AU - Jindani, A. AU - Nunn, A. J. AU - Enarson, D. A. PY - 2004 DA - 2004// TI - Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17141-9 DO - 10.1016/S0140-6736(04)17141-9 ID - Jindani2004 ER - TY - JOUR AU - Kassahun, K. AU - McIntosh, I. AU - Cui, D. AU - Hreniuk, D. AU - Merschman, S. AU - Lasseter, K. PY - 2007 DA - 2007// TI - Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme JO - Drug Metab Dispos VL - 35 UR - https://doi.org/10.1124/dmd.107.016196 DO - 10.1124/dmd.107.016196 ID - Kassahun2007 ER - TY - JOUR AU - Acosta, E. P. AU - Kendall, M. A. AU - Gerber, J. G. AU - Alston-Smith, B. AU - Koletar, S. L. AU - Zolopa, A. R. PY - 2007 DA - 2007// TI - Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.00341-07 DO - 10.1128/AAC.00341-07 ID - Acosta2007 ER - TY - JOUR AU - Burger, D. M. AU - Agarwala, S. AU - Child, M. AU - Been-Tiktak, A. AU - Wang, Y. AU - Bertz, R. PY - 2006 DA - 2006// TI - Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.00461-06 DO - 10.1128/AAC.00461-06 ID - Burger2006 ER - TY - JOUR AU - Justesen, U. S. AU - Andersen, A. B. AU - Klitgaard, N. A. AU - Brosen, K. AU - Gerstoft, J. AU - Pedersen, C. PY - 2004 DA - 2004// TI - Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/380794 DO - 10.1086/380794 ID - Justesen2004 ER - TY - JOUR AU - Schmitt, C. AU - Riek, M. AU - Winters, K. AU - Schutz, M. AU - Grange, S. PY - 2009 DA - 2009// TI - Unexpected hepatotoxicity of rifampin and saquinavir/ritonavir in healthy male volunteers JO - Arch Drug Inf VL - 2 UR - https://doi.org/10.1111/j.1753-5174.2009.00017.x DO - 10.1111/j.1753-5174.2009.00017.x ID - Schmitt2009 ER - TY - JOUR AU - Haas, D. W. AU - Koletar, S. L. AU - Laughlin, L. AU - Kendall, M. A. AU - Suckow, C. AU - Gerber, J. G. PY - 2009 DA - 2009// TI - Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir JO - J Acquir Immune Defic Syndr VL - 50 UR - https://doi.org/10.1097/QAI.0b013e318189a7df DO - 10.1097/QAI.0b013e318189a7df ID - Haas2009 ER - TY - JOUR AU - Sunpath, H. AU - Winternheimer, P. AU - Cohen, S. AU - Tennant, I. AU - Chelin, N. AU - Gandhi, R. T. PY - 2014 DA - 2014// TI - Double-dose lopinavir–ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.13.0492 DO - 10.5588/ijtld.13.0492 ID - Sunpath2014 ER - TY - JOUR AU - Lopez-Cortes, L. F. AU - Ruiz-Valderas, R. AU - Viciana, P. AU - Alarcon-Gonzalez, A. AU - Gomez-Mateos, J. AU - Leon-Jimenez, E. PY - 2002 DA - 2002// TI - Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis JO - Clin Pharmacokinet VL - 41 UR - https://doi.org/10.2165/00003088-200241090-00004 DO - 10.2165/00003088-200241090-00004 ID - Lopez-Cortes2002 ER - TY - JOUR AU - Manosuthi, W. AU - Sungkanuparph, S. AU - Thakkinstian, A. AU - Vibhagool, A. AU - Kiertiburanakul, S. AU - Rattanasiri, S. PY - 2005 DA - 2005// TI - Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000183630.27665.30 DO - 10.1097/01.aids.0000183630.27665.30 ID - Manosuthi2005 ER - TY - JOUR AU - Manosuthi, W. AU - Kiertiburanakul, S. AU - Sungkanuparph, S. AU - Ruxrungtham, K. AU - Vibhagool, A. AU - Rattanasiri, S. PY - 2006 DA - 2006// TI - Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000196181.18916.9b DO - 10.1097/01.aids.0000196181.18916.9b ID - Manosuthi2006 ER - TY - JOUR AU - Boulle, A. AU - Cutsem, G. AU - Cohen, K. AU - Hilderbrand, K. AU - Mathee, S. AU - Abrahams, M. PY - 2008 DA - 2008// TI - Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.300.5.530 DO - 10.1001/jama.300.5.530 ID - Boulle2008 ER - TY - JOUR AU - Manosuthi, W. AU - Mankatitham, W. AU - Lueangniyomkul, A. AU - Chimsuntorn, S. AU - Sungkanuparph, S. PY - 2008 DA - 2008// TI - Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin JO - HIV Med VL - 9 UR - https://doi.org/10.1111/j.1468-1293.2008.00563.x DO - 10.1111/j.1468-1293.2008.00563.x ID - Manosuthi2008 ER - TY - JOUR AU - Manosuthi, W. AU - Sungkanuparph, S. AU - Tantanathip, P. AU - Lueangniyomkul, A. AU - Mankatitham, W. AU - Prasithsirskul, W. PY - 2009 DA - 2009// TI - A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/599114 DO - 10.1086/599114 ID - Manosuthi2009 ER - TY - JOUR AU - Kwara, A. AU - Tashima, K. T. AU - Dumond, J. B. AU - Poethke, P. AU - Kurpewski, J. AU - Kashuba, A. D. PY - 2011 DA - 2011// TI - Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African–American and Caucasian volunteers JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.00980-10 DO - 10.1128/AAC.00980-10 ID - Kwara2011 ER - TY - JOUR AU - Gengiah, T. N. AU - Holford, N. H. AU - Botha, J. H. AU - Gray, A. L. AU - Naidoo, K. AU - Abdool Karim, S. S. PY - 2012 DA - 2012// TI - The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis JO - Eur J Clin Pharmacol VL - 68 UR - https://doi.org/10.1007/s00228-011-1166-5 DO - 10.1007/s00228-011-1166-5 ID - Gengiah2012 ER - TY - JOUR AU - Manosuthi, W. AU - Sukasem, C. AU - Lueangniyomkul, A. AU - Mankatitham, W. AU - Thongyen, S. AU - Nilkamhang, S. PY - 2013 DA - 2013// TI - Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.02023-12 DO - 10.1128/AAC.02023-12 ID - Manosuthi2013 ER - TY - JOUR AU - Uttayamakul, S. AU - Likanonsakul, S. AU - Manosuthi, W. AU - Wichukchinda, N. AU - Kalambaheti, T. AU - Nakayama, E. E. PY - 2010 DA - 2010// TI - Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults JO - AIDS Res Ther VL - 7 UR - https://doi.org/10.1186/1742-6405-7-8 DO - 10.1186/1742-6405-7-8 ID - Uttayamakul2010 ER - TY - JOUR AU - Ribera, E. AU - Pou, L. AU - Lopez, R. M. AU - Crespo, M. AU - Falco, V. AU - Ocana, I. PY - 2001 DA - 2001// TI - Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis JO - J Acquir Immune Defic Syndr VL - 28 UR - https://doi.org/10.1097/00042560-200112150-00007 DO - 10.1097/00042560-200112150-00007 ID - Ribera2001 ER - TY - JOUR AU - Ramachandran, G. AU - Hemanthkumar, A. K. AU - Rajasekaran, S. AU - Padmapriyadarsini, C. AU - Narendran, G. AU - Sukumar, B. PY - 2006 DA - 2006// TI - Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration JO - J Acquir Immune Defic Syndr VL - 42 ID - Ramachandran2006 ER - TY - JOUR AU - Manosuthi, W. AU - Ruxrungtham, K. AU - Likanonsakul, S. AU - Prasithsirikul, W. AU - Inthong, Y. AU - Phoorisri, T. PY - 2007 DA - 2007// TI - Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/510078 DO - 10.1086/510078 ID - Manosuthi2007 ER - TY - JOUR AU - Manosuthi, W. AU - Tantanathip, P. AU - Chimsuntorn, S. AU - Eampokarap, B. AU - Thongyen, S. AU - Nilkamhang, S. PY - 2010 DA - 2010// TI - Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study JO - Int J Infect Dis VL - 14 UR - https://doi.org/10.1016/j.ijid.2010.06.016 DO - 10.1016/j.ijid.2010.06.016 ID - Manosuthi2010 ER - TY - JOUR AU - Bonnet, M. AU - Bhatt, N. AU - Baudin, E. AU - Silva, C. AU - Michon, C. AU - Taburet, A. M. PY - 2013 DA - 2013// TI - Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial JO - Lancet Infect Dis VL - 13 UR - https://doi.org/10.1016/S1473-3099(13)70007-0 DO - 10.1016/S1473-3099(13)70007-0 ID - Bonnet2013 ER - TY - JOUR AU - Avihingsanon, A. AU - Manosuthi, W. AU - Kantipong, P. AU - Chuchotaworn, C. AU - Moolphate, S. AU - Sakornjun, W. PY - 2008 DA - 2008// TI - Pharmacokinetics and 48-week efficacy of nevirapine: 400 versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin JO - Antivir Ther. VL - 13 ID - Avihingsanon2008 ER - TY - JOUR AU - Kakuda, T. N. AU - Scholler-Gyure, M. AU - Hoetelmans, R. M. PY - 2011 DA - 2011// TI - Pharmacokinetic interactions between etravirine and non-antiretroviral drugs JO - Clin Pharmacokinet VL - 50 UR - https://doi.org/10.2165/11534740-000000000-00000 DO - 10.2165/11534740-000000000-00000 ID - Kakuda2011 ER - TY - JOUR AU - Wenning, L. A. AU - Hanley, W. D. AU - Brainard, D. M. AU - Petry, A. S. AU - Ghosh, K. AU - Jin, B. PY - 2009 DA - 2009// TI - Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.01468-08 DO - 10.1128/AAC.01468-08 ID - Wenning2009 ER - TY - JOUR AU - Grinsztejn, B. AU - Castro, N. AU - Arnold, V. AU - Veloso, V. G. AU - Morgado, M. AU - Pilotto, J. H. PY - 2014 DA - 2014// TI - Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70711-X DO - 10.1016/S1473-3099(14)70711-X ID - Grinsztejn2014 ER - TY - JOUR AU - Yee, D. AU - Valiquette, C. AU - Pelletier, M. AU - Parisien, I. AU - Rocher, I. AU - Menzies, D. PY - 2003 DA - 2003// TI - Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis JO - Am J Respir Crit Care Med VL - 167 UR - https://doi.org/10.1164/rccm.200206-626OC DO - 10.1164/rccm.200206-626OC ID - Yee2003 ER - TY - JOUR AU - Marks, D. J. AU - Dheda, K. AU - Dawson, R. AU - Ainslie, G. AU - Miller, R. F. PY - 2009 DA - 2009// TI - Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs JO - Int J STD AIDS VL - 20 UR - https://doi.org/10.1258/ijsa.2008.008361 DO - 10.1258/ijsa.2008.008361 ID - Marks2009 ER - TY - JOUR AU - Lehloenya, R. J. AU - Dheda, K. PY - 2012 DA - 2012// TI - Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future JO - Expert Rev Anti Infect Ther VL - 10 UR - https://doi.org/10.1586/eri.12.13 DO - 10.1586/eri.12.13 ID - Lehloenya2012 ER - TY - JOUR AU - Shipton, L. K. AU - Wester, C. W. AU - Stock, S. AU - Ndwapi, N. AU - Gaolathe, T. AU - Thior, I. PY - 2009 DA - 2009// TI - Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana JO - Int J Tuberc Lung Dis VL - 13 ID - Shipton2009 ER - TY - JOUR AU - Mankhatitham, W. AU - Lueangniyomkul, A. AU - Manosuthi, W. PY - 2011 DA - 2011// TI - Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen JO - Southeast Asian J Trop Med Public Health VL - 42 ID - Mankhatitham2011 ER - TY - JOUR AU - Sharma, S. K. AU - Singla, R. AU - Sarda, P. AU - Mohan, A. AU - Makharia, G. AU - Jayaswal, A. PY - 2010 DA - 2010// TI - Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity JO - Clin Infect Dis VL - 50 UR - https://doi.org/10.1086/650576 DO - 10.1086/650576 ID - Sharma2010 ER - TY - JOUR AU - Yimer, G. AU - Aderaye, G. AU - Amogne, W. AU - Makonnen, E. AU - Aklillu, E. AU - Lindquist, L. PY - 2008 DA - 2008// TI - Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0001809 DO - 10.1371/journal.pone.0001809 ID - Yimer2008 ER - TY - JOUR AU - Kenyon, C. AU - Wearne, N. AU - Burton, R. AU - Meintjes, G. PY - 2011 DA - 2011// TI - The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis JO - South Afr J HIV Med VL - 12 ID - Kenyon2011 ER - TY - JOUR AU - Plas, H. AU - Meintjes, G. AU - Schutz, C. AU - Goliath, R. AU - Myer, L. AU - Baatjie, D. PY - 2013 DA - 2013// TI - Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0054145 DO - 10.1371/journal.pone.0054145 ID - Plas2013 ER - TY - JOUR AU - Cheng, S. L. AU - Wang, H. C. AU - Yang, P. C. PY - 2007 DA - 2007// TI - Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis JO - Int J Tuberc Lung Dis VL - 11 ID - Cheng2007 ER - TY - JOUR AU - Manosuthi, W. AU - Kiertiburanakul, S. AU - Phoorisri, T. AU - Sungkanuparph, S. PY - 2006 DA - 2006// TI - Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy JO - J Infect VL - 53 UR - https://doi.org/10.1016/j.jinf.2006.01.002 DO - 10.1016/j.jinf.2006.01.002 ID - Manosuthi2006 ER - TY - JOUR AU - Manosuthi, W. AU - Tieu, H. AU - Mankatitham, W. AU - Lueangniyomkul, A. AU - Ananworanich, J. AU - Avihingsanon, A. PY - 2009 DA - 2009// TI - Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome JO - AIDS VL - 23 UR - https://doi.org/10.1097/QAD.0b013e32832f7b59 DO - 10.1097/QAD.0b013e32832f7b59 ID - Manosuthi2009 ER - TY - JOUR AU - Breen, R. A. AU - Smith, C. J. AU - Bettinson, H. AU - Dart, S. AU - Bannister, B. AU - Johnson, M. A. PY - 2004 DA - 2004// TI - Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection JO - Thorax VL - 59 UR - https://doi.org/10.1136/thx.2003.019224 DO - 10.1136/thx.2003.019224 ID - Breen2004 ER - TY - JOUR AU - Muller, M. AU - Wandel, S. AU - Colebunders, R. AU - Attia, S. AU - Furrer, H. AU - Egger, M. PY - 2010 DA - 2010// TI - Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis JO - Lancet Infect Dis VL - 10 UR - https://doi.org/10.1016/S1473-3099(10)70026-8 DO - 10.1016/S1473-3099(10)70026-8 ID - Muller2010 ER - TY - JOUR AU - Marais, S. AU - Meintjes, G. AU - Pepper, D. J. AU - Dodd, L. E. AU - Schutz, C. AU - Ismail, Z. PY - 2013 DA - 2013// TI - Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis899 DO - 10.1093/cid/cis899 ID - Marais2013 ER - TY - JOUR AU - Marais, S. AU - Scholtz, P. AU - Pepper, D. J. AU - Meintjes, G. AU - Wilkinson, R. J. AU - Candy, S. PY - 2010 DA - 2010// TI - Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome JO - Int J Tuberc Lung Dis VL - 14 ID - Marais2010 ER - TY - JOUR AU - Lawn, S. D. AU - Wood, R. PY - 2007 DA - 2007// TI - Hepatic involvement with tuberculosis-associated immune reconstitution disease JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3282f1be39 DO - 10.1097/QAD.0b013e3282f1be39 ID - Lawn2007 ER - TY - JOUR AU - Michailidis, C. AU - Pozniak, A. L. AU - Mandalia, S. AU - Basnayake, S. AU - Nelson, M. R. AU - Gazzard, B. G. PY - 2005 DA - 2005// TI - Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis JO - Antivir Ther VL - 10 ID - Michailidis2005 ER - TY - JOUR AU - Lawn, S. D. AU - Wilkinson, R. J. AU - Lipman, M. C. AU - Wood, R. PY - 2008 DA - 2008// TI - Immune reconstitution and “unmasking” of tuberculosis during antiretroviral therapy JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200709-1311PP DO - 10.1164/rccm.200709-1311PP ID - Lawn2008 ER - TY - JOUR AU - John, L. AU - Baalwa, J. AU - Kalimugogo, P. AU - Nabankema, E. AU - Castelnuovo, B. AU - Muhindo, G. PY - 2005 DA - 2005// TI - Response to ‘Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?’ JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000191922.08938.12 DO - 10.1097/01.aids.0000191922.08938.12 ID - John2005 ER - TY - JOUR AU - Lawn, S. D. AU - Wainwright, H. AU - Orrell, C. PY - 2009 DA - 2009// TI - Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages JO - AIDS VL - 23 UR - https://doi.org/10.1097/QAD.0b013e32831d2a98 DO - 10.1097/QAD.0b013e32831d2a98 ID - Lawn2009 ER - TY - JOUR AU - French, M. A. AU - Price, P. AU - Stone, S. F. PY - 2004 DA - 2004// TI - Immune restoration disease after antiretroviral therapy JO - AIDS VL - 18 UR - https://doi.org/10.1097/01.aids.0000131375.21070.06 DO - 10.1097/01.aids.0000131375.21070.06 ID - French2004 ER - TY - JOUR AU - Robertson, J. AU - Meier, M. AU - Wall, J. AU - Ying, J. AU - Fichtenbaum, C. J. PY - 2006 DA - 2006// TI - Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/503903 DO - 10.1086/503903 ID - Robertson2006 ER - TY - JOUR AU - Meintjes, G. AU - Lawn, S. D. AU - Scano, F. AU - Maartens, G. AU - French, M. A. AU - Worodria, W. PY - 2008 DA - 2008// TI - Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings JO - Lancet Infect Dis VL - 8 UR - https://doi.org/10.1016/S1473-3099(08)70184-1 DO - 10.1016/S1473-3099(08)70184-1 ID - Meintjes2008 ER - TY - JOUR AU - Breton, G. AU - Duval, X. AU - Estellat, C. AU - Poaletti, X. AU - Bonnet, D. AU - Mvondo Mvondo, D. PY - 2004 DA - 2004// TI - Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/425742 DO - 10.1086/425742 ID - Breton2004 ER - TY - JOUR AU - Worodria, W. AU - Menten, J. AU - Massinga-Loembe, M. AU - Mazakpwe, D. AU - Bagenda, D. AU - Koole, O. PY - 2012 DA - 2012// TI - Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection JO - Antivir Ther VL - 17 UR - https://doi.org/10.3851/IMP2108 DO - 10.3851/IMP2108 ID - Worodria2012 ER - TY - JOUR AU - Luetkemeyer, A. F. AU - Kendall, M. A. AU - Nyirenda, M. AU - Wu, X. AU - Ive, P. AU - Benson, C. A. PY - 2014 DA - 2014// TI - Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs JO - J Acquir Immune Defic Syndr VL - 65 UR - https://doi.org/10.1097/QAI.0000000000000030 DO - 10.1097/QAI.0000000000000030 ID - Luetkemeyer2014 ER - TY - JOUR AU - Bonnet, M. AU - Baudin, E. AU - Jani, I. V. AU - Nunes, E. AU - Verhoustraten, F. AU - Calmy, A. PY - 2013 DA - 2013// TI - Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0084585 DO - 10.1371/journal.pone.0084585 ID - Bonnet2013 ER - TY - JOUR AU - Bourgarit, A. AU - Carcelain, G. AU - Martinez, V. AU - Lascoux, C. AU - Delcey, V. AU - Gicquel, B. PY - 2006 DA - 2006// TI - Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000202648.18526.bf DO - 10.1097/01.aids.0000202648.18526.bf ID - Bourgarit2006 ER - TY - JOUR AU - Narendran, G. AU - Andrade, B. B. AU - Porter, B. O. AU - Chandrasekhar, C. AU - Venkatesan, P. AU - Menon, P. A. PY - 2013 DA - 2013// TI - Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0063541 DO - 10.1371/journal.pone.0063541 ID - Narendran2013 ER - TY - JOUR AU - Breen, R. A. AU - Smith, C. J. AU - Cropley, I. AU - Johnson, M. A. AU - Lipman, M. C. PY - 2005 DA - 2005// TI - Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000176221.33237.67 DO - 10.1097/01.aids.0000176221.33237.67 ID - Breen2005 ER - TY - JOUR AU - Meintjes, G. AU - Wilkinson, R. J. AU - Morroni, C. AU - Pepper, D. J. AU - Rebe, K. AU - Rangaka, M. X. PY - 2010 DA - 2010// TI - Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome JO - AIDS VL - 24 ID - Meintjes2010 ER - TY - JOUR AU - Lai, R. P. AU - Meintjes, G. AU - Wilkinson, R. J. PY - 2016 DA - 2016// TI - HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome JO - Semin Immunopathol VL - 38 UR - https://doi.org/10.1007/s00281-015-0532-2 DO - 10.1007/s00281-015-0532-2 ID - Lai2016 ER -